Ireland (IRLD) Form 4 Change in insider ownership

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0287
Estimated average burden
hours per response:	0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

NANOMINERALS CORP.

(Last) (First) (Middle)

3500 LAKESIDE COURT, SUITE 206

(Street)

RENO NV 89509

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IRELAND INC. [ IRLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2015

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
2014 Special Warrants (Right to Buy)	(1)	05/18/2015		M			500,000	03/24/2014	03/31/2015	Units(2)	500,000	$0	0	D
2015 Special Warrants (Right to Buy)	(3)	05/18/2015		M		500,000		05/18/2015	02/28/2016(4)	Units(5)	500,000	$0.2(1)	500,000	D

Explanation of Responses:

1. 2014 Special Warrants converted into 2015 Special Warrants pro rata to the purchase price for each ($0.20/special warrant for each).

2. Each Unit issuable under 2014 Special Warrants consisted of one share of common stock and one share purchase warrant exercisable at $0.40 per share, expiring March 19, 2019.

3. 2015 Special Warrants are convertible into Units at no extra cost on a 1:1 basis. Alternately, if the Issuer completes a Subsequent Equity Offering, holders may convert into shares of common stock or Common Stock Equivalents pro rata to the purchase price of the Subsequent Equity Offering (terms as defined in the 2015 Special Warrants).

4. 2015 Special Warrants expire on the earlier of February 28, 2016 and one month after a Qualified Financing (as defined in the 2015 Special Warrants).

5. Each Unit consists of one share of common stock and one share purchase warrant exercisable at $0.40 per share, expiring February 28, 2020.

Remarks:

The filing of this statement shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the equity securities listed in this statement for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise.

	Charles Ager, authorized signatory for Nanominerals Corp.	05/18/2015
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.